US tariff threats push Indian pharma to diversify beyond generics, American market

Indian Pharma must look at strengthening its presence in established markets in Latin America, China, Russia, Africa and East Europe. This is a timely pill for industry to take.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *